Moolec Science (MLEC) Intangibles (2022 - 2026)
Moolec Science's (MLEC) quarterly Intangibles came in at $71.6 million in Q1 2026, little changed quarter-over-quarter from $71.6 million in Q4 2025.
Moolec Science (MLEC) Intangibles (2022 - 2026) Analysis & Trends
Moolec Science has disclosed Intangibles across 5 years of filings, most recently posting $71.6 million for Q1 2026.
- Intangibles for Q1 2026 came in at $71.6 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $71.6 million (changed N/A YoY), and the FY2025 annual result was $75.3 million, down 57.56% from the prior year.
- Intangibles came in at $71.6 million for Q1 2026 at Moolec Science, roughly flat from $71.6 million in the prior quarter.
- In the past five years, Intangibles ranged from a high of $177.3 million in Q2 2024 to a low of $1.1 million in Q4 2023.
- The 5-year median for Intangibles is $8.3 million (2023), against an average of $47.0 million.
- Across the five-year window, Intangibles slumped 75.52% in 2023 and soared 6008.46% in 2025, its largest moves.
- Moolec Science's Intangibles stood at $4.7 million in 2022, then plunged by 75.52% to $1.1 million in 2023, then advanced by 2.63% to $1.2 million in 2024, then jumped by 6008.46% to $71.6 million in 2025, then changed by 0.0% to $71.6 million in 2026.
- The last three Intangibles figures came in at $71.6 million (Q1 2026), $71.6 million (Q4 2025), and $75.3 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 4.41 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 30.30 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 418.50 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 7.73 Mn |
| 10 | Moolec Science | 6.98 Bn | 6.98 Bn | - | 71.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 71.60 Mn |
| Dec 31, 2025 | 71.60 Mn |
| Jun 30, 2025 | 75.26 Mn |
| Dec 31, 2024 | 1.17 Mn |
| Sep 30, 2024 | 8.95 Mn |
| Jun 30, 2024 | 177.33 Mn |
| Mar 31, 2024 | 7.75 Mn |
| Dec 31, 2023 | 1.14 Mn |
| Sep 30, 2023 | 8.33 Mn |
| Jun 30, 2023 | 175.29 Mn |
| Mar 31, 2023 | 3.82 Mn |
| Dec 31, 2022 | 4.67 Mn |
| Jun 30, 2022 | 4.60 Mn |